SCHEMBL17295607

SCHEMBL17295607

Cc1ccc(N2C(=O)C(=Cc3ccc4c(cnn4C)c3)SC2=Nc2ccc(F)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 5/20 0.55
▸ MEN1 O00255 5/20 0.51
▸ KMT2A Q03164 5/20 0.51
▸ MAPT P10636 4/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ NPSR1 Q6W5P4 2/20 0.51
▸ BLM P54132 1/20 0.51
▸ MGAM O43451 3/20 0.45
▸ GAA P10253 1/20 0.45
▸ SI P14410 1/20 0.45
▸ MGAM2 Q2M2H8 1/20 0.45
▸ CA12 O43570 2/20 0.44
▸ CA1 P00915 2/20 0.44
▸ CA2 P00918 2/20 0.44
▸ CA9 Q16790 2/20 0.44
▸ S1PR1 P21453 2/20 0.43
▸ S1PR3 Q99500 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.41
▸ RAB9A P51151 1/20 0.40
▸ LMNA P02545 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17295605 1.00 FAAH (0.55) FAAHMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL17295434 0.85 FAAH (0.59) FAAHMEN1KMT2AMAPTNPSR1
SCHEMBL17295436 0.85 FAAH (0.59) FAAHMEN1KMT2AMAPTNPSR1
SCHEMBL17295259 0.80 FAAH (0.57) FAAHMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL17295257 0.80 FAAH (0.57) FAAHMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL17295402 0.80 ALDH1A1 (0.49) FAAHMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL17295401 0.80 ALDH1A1 (0.49) FAAHMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL17295536 0.79 FAAH (0.52) FAAHMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL17295534 0.79 FAAH (0.52) FAAHMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL17295634 0.78 FAAH (0.53) FAAHKMT2AMAPTCA9S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148990-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2017-04-05 — — EP disclosed
WO-2015181337-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2015-12-03 — — WO disclosed
Send feedback